Finger-cuff blood pressure monitors questioned by new study

Published on 12/09/2026By Zara RahmanSeasonal Wellness
Finger-cuff blood pressure monitors questioned by new study - finger cuff monitors
The randomized trial enrolled 151 healthy women undergoing elective cesarean sections under spinal anesthesia.

A study testing whether continuous finger-cuff blood pressure monitoring improves maternal safety during cesarean delivery found no meaningful advantage over standard arm-cuff measurements. The randomized trial, published in Scientific Reports, enrolled 151 healthy women undergoing elective cesarean sections under spinal anesthesia. Half received real-time finger-cuff monitoring via the Clearsight system, which uses photoplethysmography to track arterial pressure continuously, while the other half relied on intermittent oscillometric cuff readings—both groups also received prophylactic phenylephrine to prevent hypotension.

The primary goal was to measure hypotension rates, defined as systolic arterial pressure dropping below 80% of baseline. After spinal anesthesia, the incidence of hypotension was nearly identical between groups: 50.7% in the finger-cuff group versus 58.1% in the standard monitoring group, a difference that wasn’t statistically significant (P=0.358).

Secondary metrics—including the area under the curve for pressure drops, time-weighted averages, and duration of low readings, also showed no meaningful gaps. The study specifically tracked hypotension below both 80% and 70% of baseline to assess severity, but neither threshold revealed significant differences between groups. Maternal symptoms like nausea, dizziness, or bradycardia, as well as neonatal outcomes including Apgar scores and umbilical cord pH, remained consistent across both approaches.

Read Also: Breastfeeding tied to healthier postpartum lipid levels

The study’s limitations suggest why the results might not reflect real-world scenarios. Both groups received phenylephrine infusions every minute, which likely reduced the severity of pressure drops by maintaining baseline vascular tone. Additionally, the trial wasn’t powered to detect smaller differences, though a slight numerical trend favored finger-cuff monitoring, it wasn’t enough to change clinical practice. Device agreement analysis further revealed wide variability between finger-cuff and oscillometric measurements, particularly during unstable periods, reinforcing that no single method outperformed the other.

The Bland-Altman analysis showed mean differences of up to 10 mmHg during periods of rapid pressure fluctuation, indicating that clinicians must interpret readings cautiously regardless of the monitoring modality. If continuous monitoring had shown a clear benefit, it could have reshaped obstetric anesthesia protocols. Instead, the findings show that clinician response time, rather than the technology itself, remains the critical factor. The study’s authors note that finger-cuff systems may still hold value as supplementary tools, especially in high-risk cases where rapid intervention is key.

However, without larger trials confirming smaller but clinically meaningful reductions in hypotension, the standard oscillometric cuff remains the baseline. The Clearsight system’s continuous data stream could theoretically allow for earlier vasopressor adjustments, but the trial’s protocol mandated identical treatment thresholds for both groups, limiting its ability to demonstrate such advantages. For now, the data suggests that prophylactic vasopressors and close monitoring intervals, regardless of device, are more influential than the type of monitoring alone.

Read Also: NBE opens FMGE 2026 registration on September 11

The next step will be multicenter studies with broader patient populations to determine whether finger-cuff technology could justify its cost and complexity in specific settings. Until then, clinicians should treat both methods as equally valid, with the caveat that no monitoring system replaces prompt, evidence-based intervention. The study’s lead author noted that while finger-cuff technology is promising, its role in obstetric anesthesia remains unclear.

The findings align with earlier research suggesting that even advanced tools may struggle to outperform basic protocols when combined with aggressive preventive measures. The team also noted that the trial’s single-center design may have limited generalizability, as institutional protocols for hypotension management can vary significantly between obstetric anesthesia practices. The study was published in Scientific Reports under the title Non-invasive continuous versus intermittent oscillometric arterial pressure monitoring and maternal hypotension during cesarean delivery: a randomized controlled trial. The full text is available here.

You may also like

Leave a Comment

Your email address will not be published. Required fields are marked *